- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 3.1 EX-3.1
- 3.3 EX-3.3
- 4.1 EX-4.1
- 4.2 EX-4.2
- 10.1 EX-10.1
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- EX-FILING FEES Ex-filing Fees
Exhibit 99.1
CONSENT TO BE NAMED AS A DIRECTOR NOMINEE
Upstream Bio, Inc., a Delaware corporation (the “Company”), is filing a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), in connection with a public offering (the “Public Offering”) of its common stock. In connection with the Public Offering, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in the Registration Statement, and any amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to the Registration Statement and any amendments and supplements thereto.
/s/ Daniella Beckman | ||
Name: Daniella Beckman | ||
Date: September 18, 2024 |